CY1114716T1 - Ανασυσταθεντα επιφανειοδραστικα τα οποια διαθετουν βελτιωμενες ιδιοτητες - Google Patents
Ανασυσταθεντα επιφανειοδραστικα τα οποια διαθετουν βελτιωμενες ιδιοτητεςInfo
- Publication number
- CY1114716T1 CY1114716T1 CY20131101121T CY131101121T CY1114716T1 CY 1114716 T1 CY1114716 T1 CY 1114716T1 CY 20131101121 T CY20131101121 T CY 20131101121T CY 131101121 T CY131101121 T CY 131101121T CY 1114716 T1 CY1114716 T1 CY 1114716T1
- Authority
- CY
- Cyprus
- Prior art keywords
- refreshers
- improved properties
- refreshed surface
- refreshed
- surfactant
- Prior art date
Links
- 239000004094 surface-active agent Substances 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 108010007131 Pulmonary Surfactant-Associated Protein B Proteins 0.000 abstract 1
- 108010007125 Pulmonary Surfactant-Associated Protein C Proteins 0.000 abstract 1
- 102000007620 Pulmonary Surfactant-Associated Protein C Human genes 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Fire-Extinguishing Compositions (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06021521 | 2006-10-13 | ||
| EP07825212.9A EP2078038B1 (en) | 2006-10-13 | 2007-09-28 | Reconstituted surfactants having improved properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1114716T1 true CY1114716T1 (el) | 2016-10-05 |
Family
ID=39079026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20131101121T CY1114716T1 (el) | 2006-10-13 | 2013-12-11 | Ανασυσταθεντα επιφανειοδραστικα τα οποια διαθετουν βελτιωμενες ιδιοτητες |
Country Status (35)
| Country | Link |
|---|---|
| US (2) | US8183210B2 (https=) |
| EP (1) | EP2078038B1 (https=) |
| JP (2) | JP5405307B2 (https=) |
| KR (1) | KR101328851B1 (https=) |
| CN (2) | CN103169947B (https=) |
| AR (2) | AR063263A1 (https=) |
| AU (1) | AU2007306075B2 (https=) |
| BR (1) | BRPI0715317B1 (https=) |
| CA (1) | CA2666344C (https=) |
| CL (1) | CL2007002931A1 (https=) |
| CO (1) | CO6400235A2 (https=) |
| CY (1) | CY1114716T1 (https=) |
| DK (1) | DK2078038T3 (https=) |
| EA (1) | EA015802B1 (https=) |
| ES (1) | ES2438727T3 (https=) |
| GE (1) | GEP20125531B (https=) |
| HR (1) | HRP20140052T1 (https=) |
| IL (1) | IL198075A (https=) |
| JO (1) | JO2963B1 (https=) |
| MA (1) | MA31062B1 (https=) |
| ME (2) | ME02326B (https=) |
| MX (1) | MX343064B (https=) |
| MY (1) | MY148127A (https=) |
| NO (1) | NO342038B1 (https=) |
| NZ (1) | NZ576189A (https=) |
| PE (1) | PE20081184A1 (https=) |
| PL (1) | PL2078038T3 (https=) |
| PT (1) | PT2078038E (https=) |
| RS (1) | RS53172B (https=) |
| SI (1) | SI2078038T1 (https=) |
| TN (1) | TN2009000099A1 (https=) |
| TW (1) | TWI388333B (https=) |
| UA (1) | UA94477C2 (https=) |
| WO (1) | WO2008044109A1 (https=) |
| ZA (1) | ZA200902481B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8563683B2 (en) | 2006-07-20 | 2013-10-22 | University Of Rochester | Synthetic lung surfactant and use thereof |
| EP1997502A1 (en) * | 2007-06-01 | 2008-12-03 | CHIESI FARMACEUTICI S.p.A. | Reconstituted surfactants having improved properties |
| US8399406B2 (en) * | 2009-06-05 | 2013-03-19 | Chiesi Farmaceutici S.P.A. | Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C) |
| CN101948526B (zh) * | 2010-09-02 | 2012-12-05 | 华东理工大学 | 一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法 |
| EP3459556A1 (en) | 2012-02-09 | 2019-03-27 | Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | Synthetic analogs of lung surfactant protein sp-c and their use |
| US20130303726A1 (en) * | 2012-04-17 | 2013-11-14 | Chiesi Farmaceutici S.P.A. | Method for the preparation of surfactant peptides |
| AR093569A1 (es) | 2012-11-21 | 2015-06-10 | Chiesi Farm Spa | Tensioactivos pulmonares reconstituidos |
| CA3008646A1 (en) | 2015-12-17 | 2017-06-22 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Synthetic lung surfactant with enhanced stability and effectiveness |
| WO2017155857A1 (en) | 2016-03-07 | 2017-09-14 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | COMPOSITIONS AND METHODS FOR ADMINISTERING PPARγ AGONISTS, SURFACTANT PEPTIDES AND PHOSPHOLIPIDS |
| KR102395835B1 (ko) * | 2016-08-24 | 2022-05-10 | 키에시 파르마슈티시 엣스. 피. 에이. | 재구성된 폐 계면활성제 조성물을 포함하는 안정한 약제학적 제제 |
| US12606609B2 (en) | 2020-01-28 | 2026-04-21 | Chiesi Farmaceutici S.P.A. | Polypeptides having improved properties |
| US20240025970A1 (en) * | 2020-10-16 | 2024-01-25 | Sherwood Russ Lehrman | Lung treatment compositions |
| WO2025024609A1 (en) * | 2023-07-25 | 2025-01-30 | Biosuperior Technology, Inc. | Polypeptides for lung surfactant compositions |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2163860A1 (en) * | 1993-06-30 | 1995-01-12 | Chung C. Hsu | Method for preparing liposomes |
| IT1308180B1 (it) * | 1999-02-12 | 2001-12-07 | Chiesi Farma Spa | Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante |
| US7065342B1 (en) * | 1999-11-23 | 2006-06-20 | Gofigure, L.L.C. | System and mobile cellular telephone device for playing recorded music |
| ITMI20021058A1 (it) * | 2002-05-17 | 2003-11-17 | Chiesi Farma Spa | Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito |
| EP1481665A1 (en) * | 2003-05-30 | 2004-12-01 | CHIESI FARMACEUTICI S.p.A. | Novel lipid mixtures for synthetic surfactants |
| US8563683B2 (en) * | 2006-07-20 | 2013-10-22 | University Of Rochester | Synthetic lung surfactant and use thereof |
| EP1997502A1 (en) | 2007-06-01 | 2008-12-03 | CHIESI FARMACEUTICI S.p.A. | Reconstituted surfactants having improved properties |
| EP2022798A1 (en) | 2007-08-09 | 2009-02-11 | CHIESI FARMACEUTICI S.p.A. | Synthetic pulmonary surfactant peptides |
-
2007
- 2007-09-28 BR BRPI0715317-1A patent/BRPI0715317B1/pt active IP Right Grant
- 2007-09-28 HR HRP20140052TT patent/HRP20140052T1/hr unknown
- 2007-09-28 ME MEP-2016-20A patent/ME02326B/me unknown
- 2007-09-28 KR KR1020097007008A patent/KR101328851B1/ko active Active
- 2007-09-28 WO PCT/IB2007/002841 patent/WO2008044109A1/en not_active Ceased
- 2007-09-28 RS RS20140037A patent/RS53172B/sr unknown
- 2007-09-28 GE GEAP200711224A patent/GEP20125531B/en unknown
- 2007-09-28 ES ES07825212.9T patent/ES2438727T3/es active Active
- 2007-09-28 PT PT78252129T patent/PT2078038E/pt unknown
- 2007-09-28 UA UAA200903082A patent/UA94477C2/ru unknown
- 2007-09-28 PL PL07825212T patent/PL2078038T3/pl unknown
- 2007-09-28 DK DK07825212.9T patent/DK2078038T3/da active
- 2007-09-28 CN CN201310053516.8A patent/CN103169947B/zh active Active
- 2007-09-28 EP EP07825212.9A patent/EP2078038B1/en active Active
- 2007-09-28 MY MYPI20091454A patent/MY148127A/en unknown
- 2007-09-28 MX MX2009003638A patent/MX343064B/es active IP Right Grant
- 2007-09-28 NZ NZ576189A patent/NZ576189A/en unknown
- 2007-09-28 SI SI200731393T patent/SI2078038T1/sl unknown
- 2007-09-28 JP JP2009531932A patent/JP5405307B2/ja active Active
- 2007-09-28 ZA ZA200902481A patent/ZA200902481B/xx unknown
- 2007-09-28 ME MEP-121/09A patent/MEP12109A/xx unknown
- 2007-09-28 CA CA2666344A patent/CA2666344C/en active Active
- 2007-09-28 CN CN2007800382767A patent/CN101522711B/zh active Active
- 2007-09-28 AU AU2007306075A patent/AU2007306075B2/en active Active
- 2007-09-28 EA EA200900373A patent/EA015802B1/ru unknown
- 2007-10-11 TW TW096137965A patent/TWI388333B/zh active
- 2007-10-11 AR ARP070104520A patent/AR063263A1/es not_active Application Discontinuation
- 2007-10-11 PE PE2007001375A patent/PE20081184A1/es active IP Right Grant
- 2007-10-11 CL CL200702931A patent/CL2007002931A1/es unknown
- 2007-10-11 JO JO2007436A patent/JO2963B1/en active
-
2009
- 2009-03-25 TN TN2009000099A patent/TN2009000099A1/fr unknown
- 2009-04-07 IL IL198075A patent/IL198075A/en active IP Right Grant
- 2009-04-08 CO CO09036247A patent/CO6400235A2/es not_active Application Discontinuation
- 2009-04-13 US US12/422,581 patent/US8183210B2/en active Active
- 2009-04-14 NO NO20091441A patent/NO342038B1/no unknown
- 2009-05-08 MA MA31854A patent/MA31062B1/fr unknown
-
2012
- 2012-04-10 US US13/443,164 patent/US9238058B2/en active Active
-
2013
- 2013-08-02 JP JP2013161238A patent/JP2013241449A/ja active Pending
- 2013-12-11 CY CY20131101121T patent/CY1114716T1/el unknown
-
2018
- 2018-11-05 AR ARP180103211A patent/AR113422A2/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1114716T1 (el) | Ανασυσταθεντα επιφανειοδραστικα τα οποια διαθετουν βελτιωμενες ιδιοτητες | |
| CY1118676T1 (el) | Βελτιωμενη συνθεση ανασυσταμενου επιφανειοδραστικου η οποια περιεχει αναλογα της επιφανειοδραστικης πρωτεϊνης β (sp-b) και της επιφανειοδραστικης πρωτεϊνης c (sp-c) | |
| CY1118823T1 (el) | Παραγωγα πυριδινης και πυραζινης για την θεραπευτικη αντιμετωπιση της χρονιας αποφρακτικης πνευμονοπαθειας | |
| MX2019013954A (es) | Inhibidores covalentes de kras. | |
| EA200901459A1 (ru) | Реконструированные поверхностно-активные вещества, имеющие улучшенные свойства | |
| EA202091012A1 (ru) | Композиции фосфорилированных тау-пептидов и их применения | |
| CY1126231T1 (el) | Παραλλαγες ανθρωπινης αλφα-γαλακτοσιδασης | |
| CY1118665T1 (el) | Συνθεσεις και μεθοδοι για θεραπεια διαταραχων χρησης αλκοολης, πονου και αλλων ασθενειων | |
| CY1115526T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει πιμοβενδανη | |
| CY1117237T1 (el) | Συνθεσεις σταθερων τιακουμυκινων | |
| PT2121731E (pt) | Vacinas peptídicas para cancros que expressam antigénios associados a tumores | |
| CY1123623T1 (el) | Θεραπεια νευρολογικων νοσων | |
| MX391339B (es) | Composicion farmaceutica que comprende selexipag. | |
| CY1113094T1 (el) | Ανοσοσφαιρινες κατευθυνομενες εναντι nogo | |
| MX2021004331A (es) | Composiciones estables de semaglutida y usos de las mismas. | |
| CY1113726T1 (el) | Χρηση της πασιρεοτιδης για την αντιμετωπιση της ενδογενους υπερινσουλιναιμικης υπογλυκαιμιας | |
| EA202091095A1 (ru) | Пероральная доставка пептидных аналогов glp-1 | |
| SA522431748B1 (ar) | طرق لإنتاج أرجيناز 1 ناتج بمعاودة الارتباط الجيني بشري واستخداماته | |
| SA520420261B1 (ar) | تركيبات إرنوماب واستخداماتها | |
| BR112018004400A2 (pt) | composições de vacina vlp estabilizadas | |
| CO2020004244A2 (es) | Métodos y composiciones para tratar enfermedades pulmonares crónicas | |
| MX2023007992A (es) | Compuestos cuadracíclicos fundidos, composiciones y usos de los mismos. | |
| MX2024005408A (es) | Construcciones inmunogenicas y vacunas para ser utilizadas en el tratamiento profilactico y terapeutico de enfermedades causadas por sars-cov-2. | |
| EP4212172A4 (en) | Immunogenic composition targeting phosphorylated tau protein | |
| EA202191718A1 (ru) | Тканевые филлеры на основе шелка и гиалуроновой кислоты и способы их получения и применения |